Chinese biotech firm D3Bio has recently announced the completion of a US$200 million Series A financing. This round of financing is co-invested by Boyu Capital, Matrix Partners China, Sequoia China, Temasek and WuXi AppTec Venture Capital Fund.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!